Longitudinal cfDNA monitoring in one of the patients identified the appearance and increase in AF of ESR1 Y536S, ESR1 Y537S, and ESR1 Y539S which might be one potential mechanism of resistance causing progressive disease after 2 years of endocrine treatment. The gene discussed is ESR1; the disease is atrial fibrillation.